Glaucoma

Why persist with preservatives? Those present in topical glaucoma therapies don’t improve the active compound’s efficacy – and cause ocular surface disease in many patients

A light box and a 35 mm slide could be all you need for therapeutic laser target practice

Thermography could offer a noninvasive way of assessing bleb function

VR headsets could identify those with glaucoma at the greatest risk of falls

As many as six in every ten patients with glaucoma have ocular surface disease – and this can have a huge impact on their daily lives. We explore why, and what can be done.

Trimming down the number of concomitant topical glaucoma medications your patients need with MIGS devices could lead to happier patients with better-controlled IOP.

Gene therapy could provide long-term relief from elevated nocturnal IOP

The right approach can reduce the risks of post-procedural bleb failure when removing cataracts from glaucomatous eyes that have undergone prior trabeculectomy.

Current diagnostic methods for visual tests and imaging work are great, but can you obtain improved diagnoses with the addition of electrophysiological tests? For me, the answer is clear – after all, electrophysiology is no longer simply the domain of research institutes.

Mark Latina recounts his story of the invention of selective laser trabeculoplasty (SLT).